The front page of AI-driven biology
Thursday, October 15, 2026Thu, Oct 15
Updated 5:32 PM PT
Colossal Biosciences announced GenoMorph, a computational platform designed to pick out target genetic edits for de-extinction projects constrained by scarce ancient DNA.
Caribou Biosciences announced it is halting clinical development of its two allogeneic CAR-T cell therapies, conducting a substantial workforce reduction, and evaluating strategic alternatives.
Caribou Biosciences will close and discontinue its clinical pipeline after failing to secure capital for a Phase 3 study of its lead allogeneic CAR-T therapy, vispa-cel.
Updated clinical data for EPI-321 showed a 3% increase in muscle volume at six months in patients with facioscapulohumeral muscular dystrophy, or FSHD.
Researchers at Boston Children's Hospital and the Broad Institute identified the BACH2-NRF2 pathway as an independent regulator of fetal hemoglobin expression, according to a study published in Nature.
Researchers at Anthropic deployed roughly 950 Claude agents to mine genomic databases, identifying an unusual family of array-associated reverse transcriptases found in giant bacterial viruses.
Beam filed a federal lawsuit in Massachusetts accusing former scientist Zi Jun Wang of copying proprietary base editing records to co-found Shanghai-based YolTech Therapeutics.
Anthropic announced that its wet biology lab discovered an enzyme system hidden in bacteriophage DNA that functions similarly to CRISPR by cutting, copying, and pasting genetic material.
Cellectis is seeking partners to offload its clinical-stage donor-derived cell therapies for leukemia and lymphoma, lasme-cel and eti-cel, effectively ending its pioneering work in allogeneic CAR-T treatments.